Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Jae Sevelius, PhD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Phone415-502-1000 ext. 14622
ORCID ORCID Icon0000-0002-8318-038X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral Research ScholarBehavioral Medicine
    University of MissouriPhDClinical Psychology
    University of OregonPre-doctoral internship, APA-accreditedCounseling and Testing Center
    University of MissouriM.A.Gender Studies
    University of FloridaBachelor of SciencePsychology
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    Center for AIDS Prevention Studies, UCSF2010Innovative Dissemination Award
    CORO, UCSF2015UCSF CORO Faculty Leadership
    Gladstone Center for AIDS Research, UCSF2016Early Career Research Excellence Award - Behavioral Science
    CREDITS - Center for Research, Excellence, and Diversity in Team Science2017Strengthening Team Science in California
    American Psychological Association, Committee on Sexual Orientation and Gender Diversity2018Outstanding Achievement Award

    Collapse Overview 
    Collapse Overview
    I am an Associate Professor in Residence with the Center for AIDS Prevention Studies (CAPS), Division of Prevention Sciences, Department of Medicine, at the University of California, San Francisco. I lead several community-based research projects at the Center of Excellence for Transgender Health focused on leveraging data to develop culturally relevant, trauma-informed, and transgender–specific programs and interventions to promote holistic health and wellness among transgender people, with an emphasis on serving transgender women of color and those affected by HIV. I am also a licensed clinical psychologist.

    Collapse Research 
    Collapse Research Activities and Funding
    Reducing Intersectional Stigma among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP
    NIH/NIMH R01MH121308Aug 14, 2019 - May 31, 2024
    Role: Multi Principal Investigator (MPI: Lippman, Sheri)
    A couples-based approach to HIV prevention for transgender women and their male partners
    NIH R01MH115765Jul 15, 2018 - Apr 30, 2023
    Role: Multi-Principal Investigator
    Adapting the Sheroes intervention for transgender women in Brazil
    Research Evaluation & Allocation Committee - UCSF School of Medicine Jan 1, 2018 - Dec 31, 2018
    Role: Principal Investigator
    Mapping perceptions of PrEP use in transwomen and barriers to care in providers to inform intervention development
    NIH R21MH110340Apr 11, 2017 - Feb 28, 2019
    Role: Multi Principal Investigator
    TRIUMPH: Trans Research-Informed communities United in Mobilization for the Prevention of HIV
    California HIV/AIDS Research Program PR15-SF-007Apr 1, 2016 - Mar 31, 2020
    Role: Principal Investigator
    Improving engagement in HIV care for high-risk women
    NIH R01MH106373Sep 8, 2015 - Jun 30, 2020
    Role: Principal Investigator
    Culturally relevant intervention development for incarcerated transgender women
    NIH R34DA038541Sep 15, 2014 - Aug 31, 2017
    Role: Principal Investigator
    SHEROES: Cuturally relevant sexual risk reduction among high-risk women
    NIH R34MH102109Sep 26, 2013 - Jun 30, 2016
    Role: Principal Investigator
    Culturally Relevant HIV Prevention for High-Risk Women
    NIH K08MH085566Jan 1, 2009 - Feb 28, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Global Health
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Maiorana A, Sevelius J, Keatley J, Rebchook G. "She is Like a Sister to Me." Gender-Affirming Services and Relationships are Key to the Implementation of HIV Care Engagement Interventions with Transgender Women of Color. AIDS Behav. 2020 Jan 07. PMID: 31912274.
      View in: PubMed
    2. Callander, D., Schneider, J.A., Radix, A., Smith, J., Reisner, S., Poteat, T., Garofalo, R., Sevelius, J., Duncan, D.T.A Longitudinal Cohort Study of HIV-Negative Transgender Women of Color in New York City: The TURNNT (‘Trying to Understand Relationships, Networks and Neighborhoods among Transgender women of color’) Study. BMJ Open. 2020.
      View Publication
    3. Vincent W, Sevelius J, Lippman SA, Linnemayr S, Arnold EA. Identifying Opportunities for Collaboration Across the Social Sciences to Reach the 10-10-10: A Multilevel Approach. J Acquir Immune Defic Syndr. 2019 Dec 01; 82 Suppl 2:S118-S123. PMID: 31658198.
      View in: PubMed
    4. Gamarel KE, Sevelius JM, Reisner SL, Richardson RL, Darbes LA, Nemoto T, Operario D. Relationship Stigma and HIV Risk Behavior Among Cisgender Men Partnered with Transgender Women: The Moderating Role of Sexual Identity. Arch Sex Behav. 2020 Jan; 49(1):175-184. PMID: 31586272.
      View in: PubMed
    5. Sevelius JM, Neilands TB, Dilworth S, Castro D, Johnson MO. Sheroes: Feasibility and Acceptability of a Community-Driven, Group-Level HIV Intervention Program for Transgender Women. AIDS Behav. 2019 Sep 27. PMID: 31562572.
      View in: PubMed
    6. Cahill SR, Keatley J, Wade Taylor S, Sevelius J, Elsesser SA, Geffen SR, Wang T, Mayer KH. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco. AIDS Care. 2019 Sep 04; 1-9. PMID: 31482726.
      View in: PubMed
    7. Kendig NE, Cubitt A, Moss A, Sevelius J. Developing Correctional Policy, Practice, and Clinical Care Considerations for Incarcerated Transgender Patients Through Collaborative Stakeholder Engagement. J Correct Health Care. 2019 Jul; 25(3):277-286. PMID: 31242806.
      View in: PubMed
    8. George, J.R., Michaels, T.I., Sevelius, J.M., Williams, M.The Psychedelic Renaissance and the limitations of a White-dominant medical framework. Journal of Psychedelic Studies. 2019.
      View Publication
    9. Sevelius J, Chakravarty D, Neilands TB, Keatley J, Shade SB, Johnson MO, Rebchook G. Evidence for the Model of Gender Affirmation: The Role of Gender Affirmation and Healthcare Empowerment in Viral Suppression Among Transgender Women of Color Living with HIV. AIDS Behav. 2019 May 29. PMID: 31144131.
      View in: PubMed
    10. D'Avanzo PA, Bass SB, Brajuha J, Gutierrez-Mock L, Ventriglia N, Wellington C, Sevelius J. Medical Mistrust and PrEP Perceptions Among Transgender Women: A Cluster Analysis. Behav Med. 2019 Apr-Jun; 45(2):143-152. PMID: 31343968.
      View in: PubMed
    11. Blackstock, O., Platt, J., Golub, S.A. Anakaraonye, A.R., Norton, B.R. Walters, S.M., Sevelius, J.M., Cunningham, C.O.A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection. 2019.
    12. Sevelius J, Murray LR, Martinez Fernandes N, Veras MA, Grinsztejn B, Lippman SA. Optimising HIV programming for transgender women in Brazil. Cult Health Sex. 2019 May; 21(5):543-558. PMID: 30378463.
      View in: PubMed
    13. Gamarel KE, Sevelius JM, Reisner SL, Coats CS, Nemoto T, Operario D. Commitment, interpersonal stigma, and mental health in romantic relationships between transgender women and cisgender male partners. J Soc Pers Relat. 2019 Jul; 36(7):2180-2201. PMID: 31086428.
      View in: PubMed
    14. Hoffkling A, Obedin-Maliver J, Sevelius J. From erasure to opportunity: a qualitative study of the experiences of transgender men around pregnancy and recommendations for providers. BMC Pregnancy Childbirth. 2017 Nov 08; 17(Suppl 2):332. PMID: 29143629.
      View in: PubMed
    15. Sevelius J, Jenness V. Challenges and opportunities for gender-affirming healthcare for transgender women in prison. Int J Prison Health. 2017 03 13; 13(1):32-40. PMID: 28299969.
      View in: PubMed
    16. Meerwijk EL, Sevelius JM. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. Am J Public Health. 2017 Feb; 107(2):216. PMID: 28075643.
      View in: PubMed
    17. Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J; SPNS Transgender Women of Color Study Group.The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care. American Journal of Public Health. 2017.
    18. Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016; 19(7(Suppl 6)):21105. PMID: 27760683.
      View in: PubMed
    19. Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. J Acquir Immune Defic Syndr. 2016 08 15; 72 Suppl 3:S226-9. PMID: 27429187.
      View in: PubMed
    20. Radix A, Sevelius J, Deutsch MB. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices. J Int AIDS Soc. 2016; 19(3 Suppl 2):20810. PMID: 27431475.
      View in: PubMed
    21. Sevelius J, Deutsch MB, Glidden DV, Grant RM. PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply. Lancet HIV. 2016 05; 3(5):e200-1. PMID: 27126486.
      View in: PubMed
    22. Pollock L, Silva-Santisteban A, Sevelius J, Salazar X. 'You should build yourself up as a whole product': Transgender female identity in Lima, Peru. Glob Public Health. 2016 Aug-Sep; 11(7-8):981-93. PMID: 27080150.
      View in: PubMed
    23. Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, Sevelius J. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):168-71. PMID: 26910276.
      View in: PubMed
    24. Bockting W, Coleman E, Deutsch MB, Guillamon A, Meyer I, Meyer W, Reisner S, Sevelius J, Ettner R. Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):188-97. PMID: 26835800.
      View in: PubMed
    25. Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S. Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study. AIDS Behav. 2016 Apr; 20(4):928-38. PMID: 26511864.
      View in: PubMed
    26. Sevelius JM, Keatley J, Calma N, Arnold E. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016 Aug-Sep; 11(7-8):1060-75. PMID: 26963756.
      View in: PubMed
    27. Kaplan RL, Sevelius J, Ribeiro K. In the name of brevity: The problem with binary HIV risk categories. Glob Public Health. 2016 Aug-Sep; 11(7-8):824-34. PMID: 26824592.
      View in: PubMed
    28. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015 Dec; 2(12):e512-9. PMID: 26614965.
      View in: PubMed
    29. Reisner SL, White Hughto JM, Pardee D, Sevelius J. Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males. Int J STD AIDS. 2016 10; 27(11):955-66. PMID: 26384946.
      View in: PubMed
    30. Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014 Dec; 124(6):1120-7. PMID: 25415163.
      View in: PubMed
    31. Deutsch MB, Keatley J, Sevelius J, Shade SB. Collection of gender identity data using electronic medical records: survey of current end-user practices. J Assoc Nurses AIDS Care. 2014 Nov-Dec; 25(6):657-63. PMID: 24880490.
      View in: PubMed
    32. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. PMID: 24646419.
      View in: PubMed
    33. Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014 Feb; 47(1):5-16. PMID: 24317955.
      View in: PubMed
    34. Reisner SL, Bailey Z, Sevelius J. Racial/ethnic disparities in history of incarceration, experiences of victimization, and associated health indicators among transgender women in the U.S. Women Health. 2014; 54(8):750-67. PMID: 25190135.
      View in: PubMed
    35. Sevelius JM. Gender Affirmation: A Framework for Conceptualizing Risk Behavior among Transgender Women of Color. Sex Roles. 2013 Jun 01; 68(11-12):675-689. PMID: 23729971.
      View in: PubMed
    36. Jefferson K, Neilands TB, Sevelius J. Transgender women of color: discrimination and depression symptoms. Ethn Inequal Health Soc Care. 2013; 6(4):121-136. PMID: 25346778.
      View in: PubMed
    37. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. PMID: 22654510.
      View in: PubMed
    38. Sevelius JM, Keatley J, Gutierrez-Mock L. HIV/AIDS programming in the United States: considerations affecting transgender women and girls. Womens Health Issues. 2011 Nov; 21(6 Suppl):S278-82. PMID: 22055679.
      View in: PubMed
    39. Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care. 2010 May-Jun; 21(3):256-64. PMID: 20347342.
      View in: PubMed
    40. Sevelius J. "There's no pamphlet for the kind of sex I have": HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men. J Assoc Nurses AIDS Care. 2009 Sep-Oct; 20(5):398-410. PMID: 19732698.
      View in: PubMed
    41. Sevelius JM, Reznick OG, Hart SL, Schwarcz S. Informing interventions: the importance of contextual factors in the prediction of sexual risk behaviors among transgender women. AIDS Educ Prev. 2009 Apr; 21(2):113-27. PMID: 19397434.
      View in: PubMed
    42. Stake, J.E., Sevelius, J.M., Hanly, S.Student responsiveness to women's and gender studies classes: The importance of initial student attitudes and classroom relationships. NWSA Journal. 2008; 2(20):189-215.
    43. Operario D, Burton J, Underhill K, Sevelius J. Men who have sex with transgender women: challenges to category-based HIV prevention. AIDS Behav. 2008 Jan; 12(1):18-26. PMID: 17705095.
      View in: PubMed
    44. Sevelius, J.M. & Stake, J.E.The effects of prior attitudes and attitude importance on attitude change and class impact in women’s and gender studies. Journal of Applied Social Psychology. 2003; (33):2341 – 2353.
    Jae's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (135) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (17) people
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑